Todd Anderman serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Todd Anderman has executed 1 insider transactions totaling $137.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 8, 2025 involved selling 11,132 shares valued at $137.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 8, 2025 | OCUL | $137.4K | Sale | 11,132 | $12.34 | Discretionary |
Todd Anderman currently holds 87,568 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd Anderman has been a net seller of OCUL stock. They have purchased $0 and sold $137.4K worth of shares.
Todd Anderman's most recent insider trade was on Oct 8, 2025, when they sold 11,132 shares at $12.34 per share.
Get notified when new Form 4 filings are submitted